SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-041169
Filing Date
2021-08-05
Accepted
2021-08-05 07:10:16
Documents
80
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q syrs-10q_20210630.htm   iXBRL 10-Q 2769465
2 EX-3.2 syrs-ex32_186.htm EX-3.2 166171
3 EX-31.1 syrs-ex311_188.htm EX-31.1 17976
4 EX-31.2 syrs-ex312_187.htm EX-31.2 17976
5 EX-32.1 syrs-ex321_190.htm EX-32.1 5986
6 EX-32.2 syrs-ex322_189.htm EX-32.2 5986
  Complete submission text file 0001564590-21-041169.txt   10506213

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA syrs-20210630.xsd EX-101.SCH 70701
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE syrs-20210630_cal.xml EX-101.CAL 63075
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE syrs-20210630_def.xml EX-101.DEF 245868
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE syrs-20210630_lab.xml EX-101.LAB 534361
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE syrs-20210630_pre.xml EX-101.PRE 439343
12 EXTRACTED XBRL INSTANCE DOCUMENT syrs-10q_20210630_htm.xml XML 2009354
Mailing Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 617-744-1340
Syros Pharmaceuticals, Inc. (Filer) CIK: 0001556263 (see all company filings)

IRS No.: 453772460 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37813 | Film No.: 211146273
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences